You are here

Home » Content

Prostat Biyopsisi Sonrası Sepsise Bağlı Akut Böbrek Yetmezliği Gelişen Olgu

Sepsis-Induced Acute Renal Failure After Prostate Biopsy Procedure: A Case Report

Journal Name:

  • Abant Tıp Dergisi

Publication Year:

  • 2012
DOI: 
http://dx.doi.org/10.5505/abantmedj.2012.21939

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Prostate cancer is routinely diagnosed by prostate needle biopsy and recently an increasing number of patients are diagnosed prostate cancer. PSA levels, examination findings, prostate size, patient age, concomitant diseases, previous biopsy history and familial cancer burden, should be consid-ered in biopsy indication. Indication for prostate biopsy must be determined carefully in patients with comorbidities (dia-betes mellitus etc.) and more detailed information should be given to these patients in terms of the possible complica-tions. In this paper, we aimed to provide a sepsis-induced acute renal failure case in a diabetic patient after prostate biopsy procedure done.
Bookmark/Search this post with
Abstract (Original Language): 
Prostat kanseri tanısı prostat iğne biyopsisiyle konulmakta-dır. Son zamanlarda prostat kanseri tanısı alan hasta sayısı giderek artmaktadır. Biyopsi endikasyonunda PSA düzeyi, muayene bulguları, prostat büyüklüğü, hastanın yaşı, yandaş hastalıkları, daha önceki biyopsi öyküsü ve ailesindeki kanser yükü değerlendirilmeye alınmalıdır. Özellikle yandaş hastalığı (diyabetes mellitus vb.) olan hastalarda prostat biyopsisi endikasyonu konurken daha dikkatli olunmalıdır. Olası komplikasyonlar açısından hastaya daha ayrıntılı bilgi veril-melidir. Bu yazıda prostat biyopsisi sonrası sepsise bağlı akut böbrek yetmezliği gelişen diyabetes mellituslu bir hastanın sunulması amaçlandı.
FULL TEXT (PDF): 
PDF icon arastirmax-prostat-biyopsisi-sonrasi-sepsise-bagli-akut-bobrek-yetmezligi-gelisen-olgu.pdf
  • 3
168-170
  • Turkish

REFERENCES

References: 

1- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58:71-96.
2- Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of currrent guidelines, practices, and prospects. CA Cancer J Clin 2007;57:90-104.
3- Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MD, Matveev V, Mottet N, Van der Kwast TH, Wiegel T, Zattoni F. Guidlines on Prostat Cancer. Euro-pean Association of Urology 2012;18-19.
4- Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardi-no PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6.630 men. J Urol 1994;151:1283-1290.
5- Stephan C, Miller K, Jung K. Is there an optimal prostate-specific antigen threshold for prostate biopsy? Expert Rev Anticancer Ther. 2011;11:1215-1221.
6- Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA Jr. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004;350:2239-2246.
7- Kaygisiz O, Uğurlu O, Koşan M, Inal G, Oztürk B, Ce-tinkaya M. Effects of antibacterial therapy on PSA chan-
ge in the presence and absence of prostatic inflammati-on in patients with PSA levels between 4 and 10 ng/mL. Prostate Cancer Prostatic Dis 2006;9: 235-238.
8- Loeb S, Gashti SN, Catalona WJ. Exclusion of inflamma-tion in the differential diagnosis of an elevated prostate-specific antigen (PSA). Urol Oncol 2009;27: 64-66.
9- Smyth LG, Mulvin DW. Antibiotic prophylaxis for trans-rectal ultrasound biopsy of the prostate in Ireland. Ir J Med Sci 2011 Nov 6.
10- Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ. Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel: best practice po-licy statement on urologic surgery antimicrobial prophy-laxis. J Urol 2008;179:1379-1390.
11- Minamida S, Satoh T, Tabata K, Kimura M, Tsumura H, Kurosaka S, Matsumoto K, Fujita T, Iwamura M, Baba S. Prevalence of Fluoroquinolone-resistant Escherichia coli Before and Incidence of Acute Bacterial Prostatitis After Prostate Biopsy. Urology 2011;78:1235-1239.
12- Health Protection Agency. Antimicrobial resistance and prescribing in England. Wales and Northern Ireland 2008;33–34.
13- Erdogan H, Ekinci MN, Hoscan MB, Erdogan A, Arslan H. Acute bacterial meningitis after transrectal needle bi-opsy of the prostate: a case report. Prostate Cancer Prostatic Dis 2008;11:207-208.
14- Esper AM, Moss M, Martin GS. The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemio-logical study. Crit Care 2009;13:1-6.

Thank you for copying data from http://www.arastirmax.com